“Dishman holds a license agreement from Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical companies of JJ to produce active pharmaceutical ingredient (API) of Sirturo (bedaquiline),” the pharma company said in its filing to exchanges.
| Subscribe To Our Free Newsletter |
